Back to top
more

Illumina (ILMN)

(Delayed Data from NSDQ)

$161.93 USD

161.93
3,100,660

+2.84 (1.79%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $161.85 -0.08 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Illumina (ILMN) Tops Q4 Earnings & Revenues, Issues Guidance

by Zacks Equity Research

Illumina (ILMN) gains from strength in sequencing consumables and instruments as well as microarray portfolios in Q4.

    Zacks Equity Research

    Why Illumina (ILMN) Might Surprise This Earnings Season

    by Zacks Equity Research

    Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

      Zacks Equity Research

      Illumina's (ILMN) Q4 Earnings to Show Growth in All Lines

      by Zacks Equity Research

      Illumina (ILMN) expected to gain from strong revenues at Product as well as Service and other revenue segments in Q4.

        Zacks Equity Research

        Illumina (ILMN) Ties Up With Thermo Fisher for Ion AmpliSeq

        by Zacks Equity Research

        Illumina (ILMN) consistently tries to enhance NGS platform.

          Zacks Equity Research

          Pacific Biosciences Hurt by Competition in Niche Markets

          by Zacks Equity Research

          Pacific Biosciences (PACB) faces cutthroat competition in the niche space. Also, sluggishness in the European markets is a concern.

            Zacks Equity Research

            Illumina (ILMN) Looks Good: Stock Adds 6.9% in Session

            by Zacks Equity Research

            Illumina (ILMN) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

              Zacks Equity Research

              Product Innovation Drives Illumina, Downbeat Margins a Woe

              by Zacks Equity Research

              Illumina (ILMN) harbors hopes about recent launches like NovaSeq S4 flow cell and reagent kit for its NovaSeq 6000 System. A low margin scenario due to the NovaSeq launch is a concern.

                Zacks Equity Research

                Here's Why You Should Invest in Illumina (ILMN) Stock Now

                by Zacks Equity Research

                Illumina (ILMN) banks on product launches and international market prospects.

                  Mark Vickery headshot

                  Top Analyst Reports for Home Depot, Boeing & Merck

                  by Mark Vickery

                  Today's Research Daily features new research reports on 16 major stocks, including Home Depot (HD), Boeing (BA) and Merck (MRK).

                    Zacks Equity Research

                    Illumina Introduces NextSeq 550Dx, Updates Use of MiSeqDx

                    by Zacks Equity Research

                    Illumina (ILMN) expands NGS platform. The company has a solid diagnostic NGS portfolio, which includes NextSeq 550Dx and MiSeqDx.